Global prevalence of sexual dysfunction among diabetic patients from 2008 to 2022: Systematic review and meta-analysis

• Published in: Metabolism open 2023-06, Vol.18, p.100247-100247, Article 100247
• Main Authors: Gebeyehu, Natnael Atnafu, Gesese, Molalegn Melese, Tegegne, Kirubel Dagnaw, Kebede, Yenalem Solomon, Kassie, Gizachew Ambaw, Mengstie, Misganaw Asmamaw, Zemene, Melkamu Aderajaw, Bantie, Berihun, Feleke, Sefineh Fenta, Dejenie, Tadesse Asmamaw, Abebe, Endeshaw Chekol, Anley, Denekew Tenaw, Dessie, Anteneh Mengist, Bayih, Wubet Alebachew, Adela, Getachew Asmare
• Format: Article
• Language: English
• Subjects: And meta-analysis; Diabetic mellitus; Sexual dysfunction; Systematic review
• ISSN: 2589-9368; 2589-9368
• DOI: 10.1016/j.metop.2023.100247

Both men and women can have a wide range of physical, emotional, and sexual issues as a result of diabetes. One of them is sexual dysfunction, which has an effect on marital relationships as well as the effectiveness of therapy and can develop into a serious social and psychological condition. As a result, the purpose of this study was to identify the global prevalence of sexual dysfunction among diabetic patients. Science Direct, Scopus, Google Scholar, and PubMed were all searched for information. Data were extracted using Microsoft Excel (v. 14), STATA statistical software, and STATA. Publication bias was investigated by a forest plot, rank test, and Egger's regression test. To detect heterogeneity, I2 was calculated and an overall estimated analysis was performed. Subgroup analysis was done by study region and sample size. The pooled odds ratio was also computed. The study was able to include 15 of the 654 publications that were evaluated since they met the criteria. 67,040 people participated in the survey in all. The pooled global prevalence of sexual dysfunction among diabetic patients was 61.4% (95% CI: 51.80, 70.99), I2 = 71.6%. The frequency of sexual dysfunction was highest in the European region (66.05%). For males, the prevalence of sexual dysfunction was 65.91%, while for females, it was 58.81%. Patients with type 2 diabetes mellitus were more likely (71.03%) to experience sexual dysfunction. Finally, sexual dysfunction was fairly common all across the world. There were variations in the prevalence of sexual dysfunction depending on the sex, type of diabetes, and location of the study participant. Our findings imply that screening and appropriate treatment are required for diabetes persons exhibiting sexual dysfunction.